ZYBT Stock Overview

Engages in the research, development, manufacture, and sale of veterinary vaccines in China. More details

ZYBT fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	1/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 75% below our estimate of its fair value

Risk Analysis

Revenue has declined by 25.2% over the past year

Shares are highly illiquid

Profit margins (10.7%) are lower than last year (17.3%)

My Notes

Capture your thoughts, links and company narrative

Zhengye Biotechnology Holding Limited Competitors

biote

NasdaqGM:BTMD

US$214.0m

BioStem Technologies

OTCPK:BSEM

US$257.4m

Procaps Group

NasdaqGM:PROC

US$189.5m

Oramed Pharmaceuticals

NasdaqCM:ORMP

US$95.9m

Price History & Performance

Summary of share price highs, lows and changes for Zhengye Biotechnology Holding
Historical stock prices
Current Share Price	US$4.62
52 Week High	US$6.10
52 Week Low	US$3.70
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-5.02%

Recent updates

Shareholder Returns

	ZYBT	US Pharmaceuticals	US Market
7D	n/a	0.4%	-2.1%
1Y	n/a	2.2%	21.3%

Return vs Industry: Insufficient data to determine how ZYBT performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how ZYBT performed against the US Market.

Price Volatility

Is ZYBT's price volatile compared to industry and market?
ZYBT volatility
ZYBT Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	11.0%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.8%
10% least volatile stocks in US Market	3.2%

Stable Share Price: ZYBT's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine ZYBT's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2004	278	Songlin Song	www.jlzybio.com

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also exports its products to Vietnam, Pakistan, and Egypt.

Zhengye Biotechnology Holding Limited Fundamentals Summary

How do Zhengye Biotechnology Holding's earnings and revenue compare to its market cap?
ZYBT fundamental statistics
Market cap	US$212.25m
Earnings (TTM)	US$2.77m
Revenue (TTM)	US$25.88m

78.7x

P/E Ratio

8.4x

P/S Ratio

Is ZYBT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ZYBT income statement (TTM)
Revenue	CN¥189.75m
Cost of Revenue	CN¥84.42m
Gross Profit	CN¥105.33m
Other Expenses	CN¥85.04m
Earnings	CN¥20.29m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	0.43
Gross Margin	55.51%
Net Profit Margin	10.69%
Debt/Equity Ratio	25.0%

How did ZYBT perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/10 05:19
End of Day Share Price	2025/01/10 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zhengye Biotechnology Holding Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution

Zhengye Biotechnology Holding NasdaqCM:ZYBT Stock Report